Substance abuse is on the rise and COVID-19 is only amplifying the problem. As we continue to grapple with the realities of COVID-19, people who smoke or vape, use opioids or have other substance use disorders (SUDs) have become more vulnerable, as direct challenges to respiratory health cause those with SUD to be particularly susceptible to infection by the coronavirus and its associated complications. Unfortunately, medical spend and lost productivity, due to addiction, is costing employers more than $25 billion per year.
Dr. Yusuf Sherwani will shine a light on the financial and business toll addiction takes on employers. From the rising costs of substance use disorders related to healthcare, to worker productivity and absenteeism. In this seminar, Dr. Sherwani will discuss the science of habit formation as well as today’s leading addiction care solutions. From Medication-Assisted Therapy (MAT) to Cognitive Behavioral Therapy (CBT), EBN and EBA readers will leave this seminar with proven strategies to help them enable clients to combat addiction in their organization.
3 Key Learnings
1.Destigmatizing Addiction: Addiction is not a moral failing or character flaw. Substance use disorder is a chronic brain disease that can be managed with medical treatment.
2.Polysubstance Addictions: One of the most significant drivers of medical spend for employers.
3.Three Pillar Approach: The importance of individually tailored, holistic treatment.